Thank you for confirming your email
Your form was submitted.
Search Results for:
Common lung bacteria team up to evade immune defences
A study led by the Institute for Bioengineering of Catalonia (IBEC) and the Universitat Autònoma de Barcelona (UAB) has uncovered how co-infection by Pseudomonas aeruginosa and Mycobacterium abscessus, two common lung pathogens, can suppress immune responses and worsen outcomes in patients with respiratory diseases. The findings, published today in the journal Virulence, provide new insight into why polymicrobial infections are particularly difficult to treat and open the door to new therapeutic strategies.
Postdoctoral researcher at the nanoprobes and nanoswitches research group
Ref: PR-PG // Deadline: 22/05/2025
Research4talent
The event offers you the opportunity to engage with our researchers and inquire about their day-to-day work in the lab, career trajectories, work-life balance, mobility, etc. In 2024, IBEC signed … Read more
Desarrollan una IA que aporta avances relativos al alzhéimer
Un equipo de investigadores catalanes ha desarrollado una herramienta de inteligencia artificial (IA) que da un paso decisivo en la comprensión del alzhéimer y otras patologías relacionadas con la agregación de proteínas.
Predoctoral researcher at the Microenvironments for Medicine Research Group
Ref: PHD-MS // Deadline: 19/05/2025
Visit of the Wageningen University Delegation
Next Monday we are hosting a group of researchers from the Laboratory of BioNanoTechnology at Wageningen University. Join us for an engaging morning of scientific exchange, with presentations from both … Read more
“Explainable” AI cracks secret language of sticky proteins
The new AI is able to predict when and why protein aggregation occurs, a mechanism linked to Alzheimer’s and 50 other diseases that affect 500 million people. The results show great potential for research into neurodegenerative diseases and for improving drug production, reducing costs and increasing efficiency. The study, published today in Science Avances, is the result of a collaboration between the Centre for Genomic Regulation (CRG) and the Institute of Bioengineering of Catalonia (IBEC).